July 25, 2014 5:13 AM ET

Company Overview of The Global Alliance for TB Drug Development

Executive Profile

Petro Terblanche

President of Stakeholders Association and Director, The Global Alliance for TB Drug Development
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 0 different industries.

See Board Relationships
----

Background

Petro Terblanche serves as President of Stakeholders Association at The Global Alliance for TB Drug Development since November 2006. Dr. Terblanche is an Executive Director, Technology and Business Development Directorate, at the Medical Research Council of South Africa (MRC). Dr. Terblanche serves as Director of The Global Alliance for TB Drug Development. She also serves as Director at eGoli BIO. She is a member of the MRC's Strategic Management Team, and an expert ...

Corporate Headquarters

--
--, -- --

United States

Phone: --
Fax: --

Board Members Memberships

President of Stakeholders Association and Director
Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The Global Alliance for TB Drug Development, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.